Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,557.00 JPY | +0.94% |
|
+3.95% | +14.91% |
| 07-23 | AI shortens drug discovery to around 1 year in China, Insilico CEO says | RE |
| 07-21 | India Approves Takeda's Dengue Vaccine QDENGA | MT |
| Market Cap | 8,790B 53.64B 47.18B 43.83B 40.31B 75.59B 5,195B 76.95B 524B 204B 2,534B 201B 197B | P/E 2027 * |
44.3x | P/E 2028 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 12,677B 77.36B 68.04B 63.2B 58.13B 109B 7,491B 111B 756B 295B 3,654B 290B 284B | EV / Sales 2027 * |
2.73x | EV / Sales 2028 * | 2.66x |
| Free-Float |
99.26% | Yield 2027 * |
3.71% | Yield 2028 * | 3.8% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.93% | ||
| 1 week | +3.95% | ||
| Current month | +7.78% | ||
| 1 month | +10.88% | ||
| 3 months | +4.22% | ||
| 6 months | +8.60% | ||
| Current year | +14.91% |
| 1 week | 5,410 |  | 5,621 |
| 1 month | 5,000 | | 5,621 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Issuer sale | Director | -1,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | Chairman | -2,152 | 0.0001% | ||
| 10/07/26 | Issuer sale | Chief Financial Officer; Director | -16,619 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.94% | +3.95% | +27.87% | +26.01% | 54.35B | |
| +1.97% | +1.43% | +48.44% | +156.66% | 1,037B | |
| +1.42% | +3.72% | +53.32% | +52.34% | 615B | |
| +1.43% | +0.99% | +34.83% | +78.74% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.28% | 326B | |
| +1.85% | +3.57% | +37.09% | +39.87% | 293B | |
| -0.11% | +0.97% | +22.57% | +17.81% | 264B | |
| +0.25% | -3.10% | -24.44% | -42.25% | 216B | |
| +1.49% | -0.02% | +20.14% | +58.21% | 198B | |
| +0.40% | -3.99% | +15.23% | +62.28% | 162B | |
| Average | +1.48% | +0.83% | +26.88% | +47.69% | 361.18B | |
| Weighted average by Cap. | +1.72% | +1.22% | +35.75% | +74.49% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,641B 28.32B 24.91B 23.14B 21.28B 39.91B 2,743B 40.63B 277B 108B 1,338B 106B 104B | 4,713B 28.76B 25.29B 23.5B 21.61B 40.53B 2,785B 41.25B 281B 110B 1,358B 108B 106B |
| Net income | 185B 1.13B 994M 923M 849M 1.59B 109B 1.62B 11.04B 4.31B 53.39B 4.24B 4.15B | 302B 1.84B 1.62B 1.51B 1.39B 2.6B 179B 2.64B 18.01B 7.02B 87.07B 6.92B 6.77B |
| Net Debt | 3,887B 23.72B 20.86B 19.38B 17.82B 33.42B 2,297B 34.02B 232B 90.38B 1,120B 89.04B 87.11B | 3,751B 22.89B 20.13B 18.7B 17.2B 32.26B 2,217B 32.83B 224B 87.23B 1,081B 85.93B 84.07B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | JP¥5,557.00 | +0.94% | 713,000 |
| 23/07/26 | JP¥5,505.00 | -0.85% | 2,920,500 |
| 22/07/26 | JP¥5,552.00 | -0.05% | 4,253,200 |
| 21/07/26 | JP¥5,555.00 | +1.37% | 5,394,200 |
| 17/07/26 | JP¥5,480.00 | +2.53% | 5,074,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
